Loading stock data…
Sensus Healthcare, Inc. (SRTS)
$3.06+0.02 (+0.66%)
After Hours$3.06+0.00 (+0.00%)· Last close Jun 29
Sensus Healthcare, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sensus Healthcare, Inc. in the Healthcare sector is trading at $3.06 with a market capitalization of $46M. Wall Street consensus targets $5.75 (4 analysts), implying a +87.9% move over the next 12 months. The stock is currently near its 52-week low of $2.66, remaining 20.1% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 72 is overbought against a weak tape. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +87.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Overbought RSI 72 against a weak tape — risk of pullback
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.39M↓ | $4.94M↓ | $6.88M↓ | $7.32M↓ | $8.34M |
| Gross Profit | $991,000↓ | $1.90M↓ | $2.71M↓ | $2.90M↓ | $4.35M |
| Operating Income | -$4.36M↓ | -$3.15M↓ | -$2.57M↓ | -$1.94M↑ | -$2.65M |
| Net Income | -$2.63M↑ | -$3.17M↓ | -$943,000↑ | -$1.04M↑ | -$2.57M |
Peer Comparison
JNJUNHPFE
Fundamentals
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of tr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$46.28M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.19
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-17.07%
Volume
Today's trading volume
30,813
Recent News
How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes
Sensus Healthcare’s fair value estimate has been trimmed from US$6.88 to US$5.75, putting a sharper spotlight on what analysts think the stock is worth today. That shift reflects a mix of optimism and caution, as recent research weighs the SRT-100/Vision platform and 2026 reimbursement changes against execution risk and timing. Read on to see how to interpret these updated targets and what to watch as the story continues to evolve. Stay updated as the Fair Value for Sensus Healthcare shifts...
Sensus Healthcare Q1 Earnings Call Highlights
Sensus Healthcare (NASDAQ:SRTS) said its first quarter of 2026 marked a transition period as new dedicated CPT codes for superficial radiotherapy took effect, while revenue declined from the prior year due largely to the absence of sales to its historically largest customer. Chairman and Chief Exec
Sensus (SRTS) Q1 2026 Earnings Transcript
Joining me from Sensus Healthcare, Inc. are Joseph C. Sardano, Chairman and Chief Executive Officer, Michael J. Sardano, President, Chief Commercial Officer and General Counsel, and Javier Rampolla, Chief Financial Officer. As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities laws.
Pleasing Signs As A Number Of Insiders Buy Sensus Healthcare Stock
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
2 Reasons Why Wells Fargo Thinks You Should Buy Google Stock Now
2 Reasons Why Wells Fargo Thinks You Should Buy Google Stock Now